AIM IMMUNOTECH INC. Ttl Fee Amt
AIM IMMUNOTECH INC. (AIM) had Ttl Fee Amt of $23.25 as of 2026-07-09, per its S-8 filed 2026-07-09.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-07-09
- 2026-07-09: Ttl Fee Amt $23.25.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-07-09 | $23.25 S-8 · filed 2026-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |